https://www.selleckchem.com/products/cc-90001.html
BACKGROUND State policies to optimize prescriber use of Prescription Drug Monitoring Programs (PDMPs) have proliferated in recent years. Prominent policies include comprehensive mandates for prescriber use of PDMP, laws allowing delegation of PDMP access to office staff, and interstate PDMP data sharing. Evidence is limited regarding the effects of these policies on adverse opioid-related hospital events. OBJECTIVE The objective of this study was to assess the effects of 3 PDMP policies on adverse opioid-related hospital events among p